CorMedica abandons laser as heart revascularisation energy source in search for better, cheaper option
This article was originally published in Clinica
One of the three companies attempting to develop percutaneous cardiac revascularisation has abandoned the use of laser energy and will be using another, unnamed energy source to drill small holes in the inner wall of the heart in order to stimulate the growth of cardiac blood vessels.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.